Before prescribing any biologic medication, it is important to check the patient’s tuberculosis status by performing an interferon-gamma release assay. This test is used to detect TB latency and prevent reactivation of TB as a complication of biologic therapy. Other tests such as alpha-fetoprotein, spirometry, and brain-natriuretic peptide are not necessary before starting biologic treatment.

Biological Agents and Their Uses

Biological agents are substances that are used to target specific molecules or receptors in the body to treat various diseases. Adalimumab, infliximab, and etanercept are biological agents that inhibit TNF alpha, a molecule that plays a role in inflammation. These agents are used to treat Crohn’s disease and rheumatoid disease. Bevacizumab is an anti-VEGF agent that targets the growth of blood vessels in tumors. It is used to treat colorectal cancer, renal cancer, and glioblastoma. Trastuzumab is a biological agent that targets the HER receptor and is used to treat breast cancer. Imatinib is a tyrosine kinase inhibitor that is used to treat gastrointestinal stromal tumors and chronic myeloid leukemia. Basiliximab targets the IL2 binding site and is used in renal transplants. Cetuximab is an epidermal growth factor inhibitor that is used to treat EGF positive colorectal cancers. Biological agents have revolutionized the treatment of many diseases and continue to be an important area of research and development in medicine.

Acute pancreatitis can be caused by mumps virus.

The symptoms described in the scenario are consistent with acute pancreatitis. The mnemonic ‘I GET SMASHED’ is a helpful tool for identifying risk factors for this condition, and mumps virus is included in this list.

While hepatitis B and C viruses have been associated with cases of pancreatitis, they are not known to directly cause the condition. influenzae virus is also not a known cause of acute pancreatitis.

However, mumps virus is a known cause of acute pancreatitis. In addition to symptoms of pancreatitis, patients may also experience other symptoms of mumps virus. The severity of the pancreatitis is typically mild in these cases.

Acute pancreatitis is a condition that is primarily caused by gallstones and alcohol consumption in the UK. However, there are other factors that can contribute to the development of this condition. A popular mnemonic used to remember these factors is GET SMASHED, which stands for gallstones, ethanol, trauma, steroids, mumps, autoimmune diseases, scorpion venom, hypertriglyceridaemia, hyperchylomicronaemia, hypercalcaemia, hypothermia, ERCP, and certain drugs. It is important to note that pancreatitis is seven times more common in patients taking mesalazine than sulfasalazine. CT scans can show diffuse parenchymal enlargement with oedema and indistinct margins in patients with acute pancreatitis.

The coronary ligament continues as the right triangular ligament.

Structure and Relations of the Liver

The liver is divided into four lobes: the right lobe, left lobe, quadrate lobe, and caudate lobe. The right lobe is supplied by the right hepatic artery and contains Couinaud segments V to VIII, while the left lobe is supplied by the left hepatic artery and contains Couinaud segments II to IV. The quadrate lobe is part of the right lobe anatomically but functionally is part of the left, and the caudate lobe is supplied by both right and left hepatic arteries and lies behind the plane of the porta hepatis. The liver lobules are separated by portal canals that contain the portal triad: the hepatic artery, portal vein, and tributary of bile duct.

The liver has various relations with other organs in the body. Anteriorly, it is related to the diaphragm, esophagus, xiphoid process, stomach, duodenum, hepatic flexure of colon, right kidney, gallbladder, and inferior vena cava. The porta hepatis is located on the postero-inferior surface of the liver and transmits the common hepatic duct, hepatic artery, portal vein, sympathetic and parasympathetic nerve fibers, and lymphatic drainage of the liver and nodes.

The liver is supported by ligaments, including the falciform ligament, which is a two-layer fold of peritoneum from the umbilicus to the anterior liver surface and contains the ligamentum teres (remnant of the umbilical vein). The ligamentum venosum is a remnant of the ductus venosus. The liver is supplied by the hepatic artery and drained by the hepatic veins and portal vein. Its nervous supply comes from the sympathetic and parasympathetic trunks of the coeliac plexus.

Barrett’s oesophagus poses the greatest risk for the development of adenocarcinoma of the oesophagus. The patient’s symptoms of heartburn, regurgitation, and nocturnal dry cough suggest the presence of gastroesophageal reflux disease (GORD), which is characterized by the reflux of gastric acid into the oesophagus. The normal oesophageal mucosa is not well-equipped to withstand the corrosive effects of gastric acid, and thus, it undergoes metaplasia to intestinal-type columnar epithelium, resulting in Barrett’s oesophagus. This condition is highly susceptible to dysplasia and progression to adenocarcinoma, and can be identified by its salmon-colored appearance during upper endoscopy.

Achalasia, on the other hand, is a motility disorder of the oesophagus that is not associated with GORD or Barrett’s oesophagus. However, it may increase the risk of squamous cell carcinoma of the oesophagus, rather than adenocarcinoma.

Mallory-Weiss syndrome (MWS) is characterized by a mucosal tear in the oesophagus, which is typically caused by severe vomiting. It is not associated with regurgitation due to GORD.

Oesophageal perforation is usually associated with endoscopy or severe vomiting. Although the patient is at risk of oesophageal perforation due to the previous endoscopy, the question specifically pertains to the risk associated with microscopic findings.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

The secretion of bicarbonate-rich fluid from pancreas and hepatic duct cells is increased by secretin.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Intussusception, a condition that causes bowel obstruction by the invagination of proximal bowel into a more distal part, is most commonly found in infants. The ileocolic type is the most frequent, although different studies may show varying degrees of frequency for the different types. The pathogenesis of intussusception is still not fully understood, but theories include involvement of lymphoid tissue, abnormalities in inhibitory neurotransmitters, and electrolyte disturbances affecting gastric motility. Ultrasound is an effective diagnostic tool, which may reveal a target, doughnut, or pseudokidney sign. Ileoileocolic and colocolic types are less common.

Understanding Intussusception

Intussusception is a medical condition where one part of the bowel folds into the lumen of the adjacent bowel, usually around the ileocecal region. This condition is most common in infants between 6-18 months old, with boys being affected twice as often as girls. Symptoms of intussusception include severe, crampy abdominal pain, inconsolable crying, vomiting, and bloodstained stool, which is a late sign. During a paroxysm, the infant will draw their knees up and turn pale, and a sausage-shaped mass may be felt in the right upper quadrant.

To diagnose intussusception, ultrasound is now the preferred method of investigation, which may show a target-like mass. Treatment for intussusception involves reducing the bowel by air insufflation under radiological control, which is now widely used first-line compared to the traditional barium enema. If this method fails, or the child has signs of peritonitis, surgery is performed. Understanding the symptoms and treatment options for intussusception is crucial for parents and healthcare professionals to ensure prompt and effective management of this condition.

Microsatellite instability of DNA repair genes causes Lynch syndrome, which is identified by the presence of aggressive colon cancer on the right side and endometrial cancer.

Colorectal cancer can be classified into three types: sporadic, hereditary non-polyposis colorectal carcinoma (HNPCC), and familial adenomatous polyposis (FAP). Sporadic colon cancer is believed to be caused by a series of genetic mutations, including allelic loss of the APC gene, activation of the K-ras oncogene, and deletion of p53 and DCC tumor suppressor genes. HNPCC, which is an autosomal dominant condition, is the most common form of inherited colon cancer. It is caused by mutations in genes involved in DNA mismatch repair, leading to microsatellite instability. The most common genes affected are MSH2 and MLH1. Patients with HNPCC are also at a higher risk of other cancers, such as endometrial cancer. The Amsterdam criteria are sometimes used to aid diagnosis of HNPCC. FAP is a rare autosomal dominant condition that leads to the formation of hundreds of polyps by the age of 30-40 years. It is caused by a mutation in the APC gene. Patients with FAP are also at risk of duodenal tumors. A variant of FAP called Gardner’s syndrome can also feature osteomas of the skull and mandible, retinal pigmentation, thyroid carcinoma, and epidermoid cysts on the skin. Genetic testing can be done to diagnose HNPCC and FAP, and patients with FAP generally have a total colectomy with ileo-anal pouch formation in their twenties.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

Bilirubin is formed when haem, a component of red blood cells, is broken down by macrophages. Albumin, a binding protein in blood, can bind to bilirubin but does not contribute to its production. Jaundice in newborns is often caused by the breakdown of red blood cells. Urobilinogen is a byproduct of bilirubin metabolism that can be excreted through the urinary system. Glutamate, an amino acid and neurotransmitter, is not involved in bilirubin synthesis.

Understanding Bilirubin and Its Role in Jaundice

Bilirubin is a chemical by-product that is produced when red blood cells break down heme, a component found in these cells. This chemical is also found in other hepatic heme-containing proteins like myoglobin. The heme is processed within macrophages and oxidized to form biliverdin and iron. Biliverdin is then reduced to form unconjugated bilirubin, which is released into the bloodstream.

Unconjugated bilirubin is bound to albumin in the blood and then taken up by hepatocytes, where it is conjugated to make it water-soluble. From there, it is excreted into bile and enters the intestines to be broken down by intestinal bacteria. Bacterial proteases produce urobilinogen from bilirubin within the intestinal lumen, which is further processed by intestinal bacteria to form urobilin and stercobilin and excreted via the faeces. A small amount of bilirubin re-enters the portal circulation to be finally excreted via the kidneys in urine.

Jaundice occurs when bilirubin levels exceed 35 umol/l. Raised levels of unconjugated bilirubin may occur due to haemolysis, while hepatocyte defects, such as a compromised hepatocyte uptake of unconjugated bilirubin and/or defective conjugation, may occur in liver disease or deficiency of glucuronyl transferase. Raised levels of conjugated bilirubin can result from defective excretion of bilirubin, for example, Dubin-Johnson Syndrome, or cholestasis.

Cholestasis can result from a wide range of pathologies, which can be largely divided into physical causes, for example, gallstones, pancreatic and cholangiocarcinoma, or functional causes, for example, drug-induced, pregnancy-related and postoperative cholestasis. Understanding bilirubin and its role in jaundice is important in diagnosing and treating various liver and blood disorders.

Based on the location of the hernia, which is superior and medial to the pubic tubercle, it is likely an inguinal hernia rather than a femoral hernia which would be located inferior and lateral to the pubic tubercle.

If the hernia is a direct inguinal hernia, it would have entered the inguinal canal by passing through the posterior wall of the canal instead of the deep inguinal ring. Therefore, it would reappear despite pressure on the deep inguinal ring.

On the other hand, if the hernia is an indirect inguinal hernia, it would have entered the inguinal canal through the deep inguinal ring and exited at the superficial inguinal ring. In this case, it would not reappear if the deep inguinal ring was occluded.

Since the hernia is reducible, it is not incarcerated.

Lastly, a spigelian hernia occurs when there is a herniation through the spigelian fascia, which is located along the semilunar line.

Understanding Inguinal Hernias

Inguinal hernias are the most common type of abdominal wall hernias, with 75% of cases falling under this category. They are more prevalent in men, with a 25% lifetime risk of developing one. The main symptom is a lump in the groin area, which disappears when pressure is applied or when the patient lies down. Discomfort and aching are also common, especially during physical activity. However, severe pain is rare, and strangulation is even rarer.

The traditional classification of inguinal hernias into indirect and direct types is no longer relevant in clinical management. Instead, the current consensus is to treat medically fit patients, even if they are asymptomatic. A hernia truss may be an option for those who are not fit for surgery, but it has limited use in other patients. Mesh repair is the preferred method, as it has the lowest recurrence rate. Unilateral hernias are usually repaired through an open approach, while bilateral and recurrent hernias are repaired laparoscopically.

After surgery, patients are advised to return to non-manual work after 2-3 weeks for open repair and 1-2 weeks for laparoscopic repair. Complications may include early bruising and wound infection, as well as late chronic pain and recurrence. It is important to seek medical attention if any of these symptoms occur.